Basel Medical Group Ltd announced a 1-for-12 reverse share split effective June 22, 2026, to comply with Nasdaq Marketplace Rule 5550(a)(2) regarding minimum bid price requirements. The consolidation of shares will reduce the number of issued and outstanding ordinary shares from 18,785,750 to approximately 1,565,480. Basel Medical Group Ltd is a medical clinic operator in Singapore.